Jonathan Moore
Fondateur chez Avvinity Therapeutics Ltd.
Profil
Jonathan David Moore is the founder of Avvinity Therapeutics Ltd.
(founded in 2016) and Epitopea Ltd.
(founded in 2021), where he holds the titles of Non-Executive Director and Chief Executive Officer & Director, respectively.
He is currently a Director at Pencil Biosciences Ltd.
(since 2019), an Operating Partner at Advent Venture Partners LLP (since 2018), and a Trustee at Aston Tower Multi-Academy Trust.
He previously held the position of Chief Executive Officer at Pheno Therapeutics Ltd.
and Chief Scientific Officer & VP-Oncology at Horizon Discovery Ltd.
He also served as Chief Scientific Officer at Horizon Discovery Group Ltd.
Dr. Moore holds a doctorate degree from Newcastle University.
Postes actifs de Jonathan Moore
| Sociétés | Poste | Début |
|---|---|---|
Avvinity Therapeutics Ltd.
 Avvinity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Avvinity Therapeutics Ltd. develops novel immuno-therapeutics. The British company was founded in 2016 by Mike Westby, Jonathan David Moore. The CEO is Nick Staples. | Fondateur | 01/01/2016 |
Pencil Biosciences Ltd.
 Pencil Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Pencil Biosciences Ltd. develops gene modulation technology. The company was founded on November 5, 2018 and is headquartered in Macclesfield, the United Kingdom. | Directeur/Membre du Conseil | 20/11/2019 |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 01/01/2018 |
Aston Tower Multi-Academy Trust
 Aston Tower Multi-Academy Trust Investment Trusts/Mutual FundsMiscellaneous Aston Tower Multi-Academy Trust is a British educational institution management company founded in 2016. The non-profit company is based in Birmingham, UK. The company manages educational institutions. | Directeur/Membre du Conseil | - |
Epitopea Ltd.
 Epitopea Ltd. Miscellaneous Commercial ServicesCommercial Services Epitopea Ltd. is a British transatlantic biotechnology company that develops immunotherapies to treat cancer by targeting a new class of antigens that are broadly shared between patients with the same cancer indication. The company is based in Cambridge, UK. The company has an extensive proprietary library of cryptigen™ tsas that will drive the development of transformational off the shelf cancer immunotherapies. Epitopea was founded in 2021 by Jonathan David Moore, Claude Perreault, and Pierre Thibault. Jonathan David Moore has been the CEO since 2021. | Fondateur | 01/01/2021 |
Anciens postes connus de Jonathan Moore
| Sociétés | Poste | Fin |
|---|---|---|
Pheno Therapeutics Ltd.
 Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom. | Directeur Général | 02/03/2022 |
Horizon Discovery Ltd.
 Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Directeur Technique/Scientifique/R&D | 01/12/2018 |
| HORIZON DISCOVERY GROUP PLC | Directeur Technique/Scientifique/R&D | - |
Formation de Jonathan Moore
| Newcastle University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
Horizon Discovery Group Ltd.
 Horizon Discovery Group Ltd. Medical SpecialtiesHealth Technology Horizon Discovery Group Ltd. is a cell engineering company, which engages in the design and engineering of genetically-modified cells. The firm operates through the following business segments: Products, Services, and Leveraged Research & Development. The Products segment sells cell lines and other products. The Services segment offers cell line manufacturing services. The Leveraged Research & Development segment business unit is operated on a portfolio basis. It serves pharmaceutical, biotechnology, and diagnostic companies. The company was founded by Christopher John Torrance, Adam John Collier, and Alberto Bardelli in July 2005 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Avvinity Therapeutics Ltd.
Avvinity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Avvinity Therapeutics Ltd. develops novel immuno-therapeutics. The British company was founded in 2016 by Mike Westby, Jonathan David Moore. The CEO is Nick Staples. | Health Technology |
Aston Tower Multi-Academy Trust
Aston Tower Multi-Academy Trust Investment Trusts/Mutual FundsMiscellaneous Aston Tower Multi-Academy Trust is a British educational institution management company founded in 2016. The non-profit company is based in Birmingham, UK. The company manages educational institutions. | Miscellaneous |
Pheno Therapeutics Ltd.
Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
Pencil Biosciences Ltd.
Pencil Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Pencil Biosciences Ltd. develops gene modulation technology. The company was founded on November 5, 2018 and is headquartered in Macclesfield, the United Kingdom. | Commercial Services |
Epitopea Ltd.
Epitopea Ltd. Miscellaneous Commercial ServicesCommercial Services Epitopea Ltd. is a British transatlantic biotechnology company that develops immunotherapies to treat cancer by targeting a new class of antigens that are broadly shared between patients with the same cancer indication. The company is based in Cambridge, UK. The company has an extensive proprietary library of cryptigen™ tsas that will drive the development of transformational off the shelf cancer immunotherapies. Epitopea was founded in 2021 by Jonathan David Moore, Claude Perreault, and Pierre Thibault. Jonathan David Moore has been the CEO since 2021. | Commercial Services |
Horizon Discovery Ltd.
Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
